Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

zinpentraxin alfa

A fully recombinant form of the human pentraxin 2 (PTX2) protein with potential antifibrotic activity. Upon intravenous administration, zinpentraxin alfa may inhibit myofibroblast generation by preventing the differentiation of circulating monocytes into fibrocytes and profibrotic macrophages. PTX2 is a circulating plasma protein that belongs to the class of pattern recognition receptors (PRR) of the innate immune system.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	pentraxin 2 PRM-151/PTX2 recombinant human pentraxin 2 recombinant human PTX2 recombinant human serum amyloid P
Code name:	PRM-151 PRM151

zinpentraxin alfa

Search NCI's Drug Dictionary